Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Kangmei Pharmaceutical

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$18M
Portfolio companies 3
Rounds per year 0.12
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Automotive
  • Finance
  • Medical
  • Advice
  • Test and Measurement
Summary

Kangmei Pharmaceutical is the famous Corporate Investor, which was founded in 1997. The venture was found in Asia in China. The main office of represented Corporate Investor is situated in the Guangdong.

The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018. The important activity for fund was in 2017.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Yichechuxing, Twist Bioscience Among the most popular fund investment industries, there are Health Care, Chemical. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Kangmei Pharmaceutical, startups are often financed by Asset Management Ventures (AMV), Paladin Capital Group, NanoDimension. The meaningful sponsors for the fund in investment in the same round are Reinet Investments S.C.A., NFT Investment, FIS.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arosa Capital Management -
Clarkston-Potomac Durham, North Carolina, United States
CP Holdings Anhui, China, Macao
Emerson Ventures Canada, Ontario, Toronto
First Partners Holding 5 Norway, Oslo
Georgia State University Atlanta, Georgia, United States
HMC Ventures China, Hangzhou, Zhejiang
INTCO Medical China, Shandong, Zibo
Kairos Angels -
Lumos Capital Group California, San Francisco, United States
Macomb Community College Michigan, United States, Warren
MassChallenge Switzerland Renens, Switzerland, Vaud
National Treasury Management Agency (NTMA) County Dublin, Dublin, Ireland
NIIF Ltd. India, Maharashtra, Mumbai
Oracle Investment Management Inc. Connecticut, Greenwich, United States
Steel City Capital Funding -
Sybat France, Gennevilliers, Ile-de-France
The Hina Group California, San Francisco, United States
Van Wickle Ventures Providence, Rhode Island, United States
Zhihe Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ZYBC

Advice
Medical
Test and Measurement
$1M31 Dec 2017 Dongcheng District, Beijing, China

Yichechuxing

Automotive
Finance
$26M12 Dec 2017 Futian District, Guangdong Province, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Kangmei Pharmaceutical?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 18M
Rounds per year 0.12
Peak activity year 2017
Lead investments 1
Exits 1
Group Appearance index 0.67

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ZYBC

Advice
Medical
Test and Measurement
$1M31 Dec 2017 Dongcheng District, Beijing, China

Yichechuxing

Automotive
Finance
$26M12 Dec 2017 Futian District, Guangdong Province, China
Crunchbase icon

Content report

The following text will be sent to our editors: